Not long ago, a diagnosis of uveal melanoma meant losing an eye, if the patient was lucky. In the worst cases, it meant chemotherapy followed by a painful death as the cancer spread. But now, specialists report that everything is changing, and the innovations are poised to save the eyesight and lives of many, according to a report in Medscape.
Trials of genetic testing, laser ablation, a first-in-class targeted light-activation therapy, and immunotherapy have all delivered striking preliminary results. "There's a lot going on in oncology," said Carol Shields, MD, from Thomas Jefferson University in Philadelphia.
Some of these treatments could enable retina specialists to take on uveal melanoma in their own offices, rather than referring patients to oncologists as they do now.